Organisation Clinique Diagnostic Research Formation
Home  <  Research  <  Publications  <  Archives 2002-2007 Plan d'accèsPlan du siteImprimer
  Search
  
Archives 2002-2007
Service d'immunologie et allergie
CHUV BH19-610
Rue du Bugnon 46
1011 Lausanne
Répondants du site: ial.info@chuv.ch
www.chuv.ch

2002   |  2003   |  2004   |  2005   |  2006   |  2007


Publications : 2007 Debut de page
1: Aubert V., Mayerat C., Lopez N. and Pantaleo G.
    Sequence analysis of the novel HLA-B35 (B*3576) allele in an African individual.
Tissue Antigens 2007, 70:439-441.
2: Barbey C., Pradervand E., Barbier N. and Spertini F.
    Ex vivo monitoring of antigen specific CD4+ T cells after recall immunization with Tetanus toxoid.
Clin. Vaccine Immunol. 2007, 14:1108-1116.
3: Bart P.-A.
    New trends in asthma therapy: is there a place for biologicals in 2007 ?
Rev. Med. Suisse 2007, 3:103-106.
4: Bonner A., Perrier C., Corthésy B. and Perkins S.J.
    Solution structure of human secretory component and implications for biological function.
J. Biol. Chem. 2007, 282:16969-16980.
5: Botez S., Carota A., Dunand M., Du Pasquier R., Kuntzer T., Michel P., Morier J., Schluep M. and Rossetti A.O.
    Neurology.
Rev. Med. Suisse 2007, 3:39-47.
6: Bouchard M., Masquelier B., Moreno M., Deibis L., de Pérez G., Fleury H. and Castro E.
    HIV type 1 drug resistance among naive patients from Venezuela.
AIDS Res. Hum. Retroviruses 2007, 23:482-485.
7: Boyman O., Conrad C., Tonel G., Gilliet M. and Nestle F.O.
    The pathogenic role of tissue-resident immune cells in psoriasis.
Trends Immunol. 2007, 28:51-57.
8: Boyman O., Purton J.F., Surh C.D. and Sprent J.
    Cytokines and T-cell homeostasis.
Curr. Opin. Immunol. 2007, 19:320-326.
9: Burgisser P., Vaudaux J. and Bart P.-A.
    Severe interference between retinal angiography and automated four-color flow cytometry analysis of blood mononuclear cells.
Cytometry A. 2007, 71A:632-636.
10: Cellerai C., Harari A., Vallelian F., Boyman O. and Pantaleo G.
    Functional and phenotypic characterization of tetanus toxoid-specific human CD4(+) T cells following re-immunization.
Eur. J. Immunol. 2007, 37:1129-1138.
11: Cho J.H., Boyman O., Kim H.O., Hahm B., Rubinstein M.P., Ramsey C., Kim D.M., Surh C.D. and Sprent J.
    An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2.
J. Exp. Med. 2007, 204:1787-1801.
12: Ciuffreda D., Pantaleo G. and Pascual M.
    Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation.
Transpl. Int. 2007, 20:649-558.
13: Codarri L., Vallotton L., Ciuffreda D., Venetz J.P., Garcia M., Hadaya K., Buhler L., Rotman S., Pascual M. and Pantaleo G.
    Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7R{alpha}high cell population in solid organ transplant recipients.
J. Exp. Med. 2007, 204:1533-1541.
14: Conrad C., Boyman O., Tonel G., Tun-Kyi A., Laggner U., de Fougerolles A., Kotelianski V., Gardner H. and Nestle F.O.
    alpha(1)beta(1) integrin is crucial for accumulation of epidermal T cells and the development of psoriasis.
Nat. Med. 2007, 13:836-842.
15: Correa R., Harari A., Vallelian F., Resino S., Munoz-Fernandez M.A. and Pantaleo G.
    Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure.
AIDS 2007, 21:23-30.
16: Corthésy B.
    Roundtrip ticket for secretory IgA: Role in mucosal homeostasis ?
J. Immunol. 2007, 178:27-32.
17: Corthésy B., Gaskins H.R. and Mercenier A.
    Cross-talk between probiotic bacteria and the host immune system.
J. Nutr. 2007, 137:781S-790S.
18: Deruaz C.A., Spertini F., Souza Lima F., Du Pasquier R.A. and Schluep M.
    Anaphylactic reaction to methylprednisolone in multiple sclerosis: a practical approach to alternative corticosteroids.
Mult. Scler. 2007, 13:559-560.
19: Du Pasquier R.
    Limbic encephalitis: another example of molecular mimicry ?
Eur. Neurol. 2007, 57:191-192.
20: Fasching C.E., Grossman T., Corthésy B., Plaut A.G., Weiser J.N. and Janoff E.N.
    Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae.
Infect. Immun. 2007, 75:1801-1810.
21: Giulieri S., Schiffer V., Yerly S., Bürgisser P., Hirschel B. and Cavassini M.
    The trap: professional exposure to human immunodeficiency virus antibody negative blood with high viral load.
Arch. Intern. Med. 2007, 167:2524-2526.
22: Gomez C.E., Najera J.L., Jimenez E.P., Jimenez V., Wagner R., Graf M., Frachette M.J., Liljestrom P., Pantaleo G. and Esteban M.
    Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.
Vaccine 2007, 25:2863-2885.
23: Gomez C.E., Najera J.L., Jimenez V., Bieler K., Wild J., Kostic L., Heidari S., Chen M., Frachette M.J., Pantaleo G., Wolf H., Liljestrom P., Wagner R. and Esteban M.
    Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
Vaccine 2007, 25:1969-1992.
24: Harari A., Cellerai C., Bellutti Enders F., Köstler J., Codarri L., Tapia G., Boyman O., Castro E., Gaudieri S., James I., John M., Wagner R., Mallal S. and Pantaleo G.
    Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype.
Proc. Natl. Acad. Sci. USA. 2007, 104:16233-16238.
25: Jilek S., Kuhle J., Meylan P., Reichhart M.D., Pantaleo G. and Du Pasquier R.A.
    Severe post-EBV encephalopathy associated with myelin oligodendrocyte glycoprotein-specific immune response.
J. Neuroimmunol. 2007, 192:192-197.
26: Jilek S., Schluep M., Rosseti A.O., Guignard L., Le Goff G., Pantaleo G. and Du Pasquier R.A.
    CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis.
Clin. Immunol. 2007, 123:105-113.
27: Kadaoui K.A. and Corthésy B.
    Secretory IgA mediates bacterial translocation to dendritic cells in mouse Peyer's patches with restriction to mucosal compartment.
J. Immunol. 2007, 179:7751-7757.
28: Krieg C., Boyman O., Fu Y.X. and Kaye J.
    B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation.
Nat. Immunol. 2007, 8:162-171.
29: Leimgruber A.
    Treatment of asthma and rhinits during pregnancy and breast feeding.
Rev. Med. Suisse 2007, 3:1044-1046, 1048-1049.
30: Mantel P.Y., Kuipers H., Boyman O., Rhyner C., Ouaked N., Rückert B., Karagiannidis C., Lambrecht B.N., Hendriks R.W., Crameri R., Akdis C.A., Blaser K. and Schmidt-Weber CB.
    GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells.
PLoS Biol. 2007, 5:2847-2861.
31: Mantis N.J., Palaia J., Hessell A.J., Mehta S., Zhu Z., Corthésy B., Neutra M.R., Burton D.R. and Janoff E.N.
    Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region.
J. Immunol. 2007, 179:3144-3152.
32: Meier P., Spertini F., Blanc E. and Burnier M.
    Oxidized low-density lipoproteins activate CD4+ T cell apoptosis in patients with end-stage renal disease through Fas engagement.
J. Am. Soc. Nephrol. 2007, 18:331-342.
33: Peters B.S., Jaoko W., Vardas E., Panayotakopoulos G., Fast P., Schmidt C., Gilmour J., Bogoshi M., Omosa-Manyonyi G., Dally L., Klavinskis L., Farah B., Tarragona T., Bart P.-A., Robinson A., Pieterse C., Stevens W., Thomas R., Barin B., McMichaelk A.J., McIntyre J.A., Pantaleo G., Hanke T. and Bwayo J.
    Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity.
Vaccine 2007, 25:2120-2127.
34: Petitpierre S., Bart P.-A., Leimgruber A., Prior J. and Spertini F.
    Large vessel vasculitis: giant cell arteritis and Takayasu arteritis.
Rev. Med. Suisse 2007, 3:1056-1060, 1062-1063.
35: Ponvert C., Weilenmann C., Wassenberg J., Walecki P., Bourgeois M.L., de Blic J. and Scheinmann P.
    Allergy to betalactam antibiotics in children: a prospective follow-up study in retreated children after negative responses in skin and challenge tests.
Allergy 2007, 62:42-46.
36: Precopio M.L., Betts M.R., Parrino J., Price D.A., Gostick E., Ambrozak D.R., Asher T.E., Douek D.C., Harari A., Pantaleo G., Bailer R., Graham B.S., Roederer M. and Koup R.A.
    Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses.
J. Exp. Med. 2007, 204:1405-1416.
37: Samri A., Goodall R., Burton C., Imami N., Pantaleo G., Kelleher A., Poli G., Gotch F. and Autran B.
    Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease.
Antivir. Ther. 2007, 12:553-558.
38: Schüpbach J., Gebhardt M.D., Tomasik Z., Niederhauser C., Yerly S., Bürgisser P., Matter L., Gorgievski M., Dubs R., Schultze D., Steffen I., Andreutti C., Martinetti G., Güntert B., Staub R., Daneel S. and Vernazza P.
    Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.
PLoS Med. 2007, 4:1921-1930.
39: Shi L., Qiu D., Zhao G., Corthésy B., Lees-Miller S., Reeves W.H. and Kao P.N.
    Dynamic binding of Ku80, Ku70 and NF90 to the IL-2 promoter in vivo in activated T-cells.
Nucleic Acids Res. 2007, 35:2302-2310.
40: Spertini F.
    New concepts for the therapy of systemic lupus erythematosus.
Rev. Med. Suisse 2007, 3:98-102.
41: Tran C., Du Pasquier R.A., Cavassini M., Guex-Crosier Y., Meuli R., Ciuffreda D. and Waeber G.
    Neuromyelitis optica following CMV primo-infection.
J. Intern. Med. 2007, 261:500-503.
42: Von Wyl V., Yerly S., Boni J., Burgisser P., Klimkait T., Battegay M., Furrer H., Telenti A., Hirschel B., Vernazza P.L., Bernasconi E., Rickenbach M., Perrin L., Ledergerber B. and Gunthard H.F.; for the Swiss HIV Cohort Study.
    Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types.
Arch. Intern. Med. 2007, 167:1782-1790.
43: Wassenberg J. and Hofer M.
    Lupine-induced anaphylaxis in a child without known food allergy.
Ann. Allergy Asthma Immunol. 2007, 98:589-590.
44: Wassenberg J., Ciuffreda D., Bart P.-A., Leimgruber A. and Spertini F.
    Modern nutrition and development of new allergies.
Rev. Med. Suisse 2007, 3:1032-1034, 1036-1037.
45: Yang W., Beaudoin E.L., Lu L., Du Pasquier R.A., Kuroda M.J., Willemsen R.A., Koralnik I.J. and Junghans R.P.
    Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML).
Int. Immunol. 2007, 19:1083-1093.
46: Yerly S., von Wyl V., Ledergerber B., Böni J., Schüpbach J., Bürgisser P., Klimkait T., Rickenbach M., Kaiser L., Günthard H.F. and Perrin L.; Swiss HIV Cohort Study.
    Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.
AIDS 2007, 21:2223-2229.

Publications : 2006 Debut de page
1: Affolter M., Bergonzelli G.E., Blaser K., Blum-Sperisen S., Corthésy B., Fay L.B., Garcia-Rodenas C., Lopes L.V., Marvin-Guy L., Mercenier A., Mutch D.M., Panchaud A., Raymond F., Schmidt-Weber C., Schumann A., Spertini F., Williamson G. and Kussmann M.
    Omics for prevention: gene, protein and metabolite profiling to better understand individual disposition to disease.
Nestle Nutr. Workshop Ser. Pediatr. Program 2006, 57:247-255.
2: Barroso S., Rieubland C., Jose alvarez A., Lopez-Trascasa M., Bart P.-A., Nunez-Roldan A. and Sanchez B.
    Molecular defects of the C7 gene in two patients with complement C7 deficiency.
Immunology 2006, 118:257-260.
3: Bart P.-A. and Pantaleo G.
    Immune-based interventions in HIV infection: doing the right studies, getting the right answers.
AIDS 2006, 20:617-618.
4: Bart P.-A. and Waeber B.
    Understanding the Raynaud's phenomenon: towards a better treatment.
Rev. Med. Suisse 2006, 2:93-96.
5: Bart P.-A., Harari A. and Pantaleo G.
    Clinical studies of experimental vaccines.
Curr. Opin. HIV AIDS 2006, 1:286-294.
6: Bernasconi E., Fritsché R. and Corthésy B.
    Specific effects of denaturation, hydrolysis and exposure to Lactococcus lactis on bovine beta-lactoglobulin transepithelial transport, antigenicity and allergenicity.
Clin. Exp. Allergy 2006, 36:803-814.
7: Boyman O., Cho J.H., Tan J.T., Surh C.D. and Sprent J.
    A major histocompatibility complex class I-dependent subset of memory phenotype CD8+ cells.
J. Exp. Med. 2006, 203:1817-1825.
8: Boyman O., Surh C.D. and Sprent J.
    Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease.
Expert Opin. Biol. Ther. 2006, 6:1323-1331.
9: Chen Y., Trofe J., Gordon J., Du Pasquier R.A., Roy-Chaudhury P., Kuroda M.J., Woodle E.S., Khalili K. and Koralnik I.J.
    immune complexes for the treatment of cancer and autoimmune disease.
J. Virol. 2006, 80:3495-3505.
10: Cornet S., Menez-Jamet J., Lemonnier F., Kosmatopoulos K. and Miconnet I.
    CpG oligodeoxynucleotides activate dendritic cells in vivo and induce a functional and protective vaccine immunity against a TERT derived modified cryptic MHC class I-restricted epitope.
Vaccine 2006, 24:1880-1888.
11: Cornet S., Miconnet I., Menez J., Lemonnier F. and Kosmatopoulos K.
    Optimal organization of a polypeptide-based candidate cancer vaccine composed of cryptic tumor peptides with enhanced immunogenicity.
Vaccine 2006, 24:2102-2109.
12: Corthésy B., Benureau Y., Perrier C., Fourgeux C., Parez N., Greenberg H. and Schwartz-Cornil I.
    Rotavirus anti-VP6 secretory IgA contributes to protection via intracellular neutralization but not via immune exclusion.
J. Virol. 2006, 80:10692-10699.
13: Dayer J.-M. and Spertini F.
    In Process Citation.
Rev. Med. Suisse 2006, 2:1019.
14: Dieudonne M., Garzaro D., Torres J., Naranjo L., Suàrez J.A., Castro J., Martínez N., Castro E., Berrueta L., Salmen S., Devesa M., Rangel H.R. and Pujol F.H.
    High prevalence of secondary resistance mutations in Venezuelan HIV-1 isolates.
Invest. Clin. 2006, 47:27-34.
15: Du Pasquier R.A., Stein M.C., Lima M.A., Dang X., Jean-Jacques J., Zheng Y., Letvin N.L. and Koralnik I.J.
    JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients.
J. Neuroimmunol. 2006, 176:181-186.
16: Ferrari-Lacraz S., Aubert V., Buhler L., Pascual M., Andresen I., Binet I., Martin P.-Y. and Villard J.
    Anti-HLA antibody repertoire after IVIg infusion in highly sensitised patients waiting for kidney transplantation.
Swiss Med. Wkly 2006:136:696-702.
17: Fontana M., Ruchat P., Horisberger J., Aubert V., Mayor C. and Spertini F.
    Prevention of cryoprecipitation during cardiopulmonary bypass in a patient with HIV-HCV co-infections.
Perfusion 2006, 21:263-265.
18: Furger P., Berger A., Bounameaux H., Burri H., Buclin T., Fumeaux T., Leimgruber A., Sarasin F., Schmidt P, Martin Suter T., Pruvot E., Reichart M. and Zanetti G.
    Patient with HIV-HCV co-infections.
Editions D & F GMBH, Suisse 2006, p1-564.
19: Harari A., Cellerai C. and Pantaleo G.
    Role of HIV-1-specific CD4 T cells.
Curr. Opin. HIV AIDS 2006, 1:22-27.
20: Harari A., Dutoit V., Cellerai C., Bart P.-A., Du Pasquier R.A. and Pantaleo G.
    Functional signatures of protective antiviral T-cell immunity in human virus infections.
Immunol. Rev. 2006, 211:236-254.
21: Lalive P.H., Schluep M., Chofflon M. and Du Pasquier R.
    Immunité et neurodégénérescence: nouveaux concepts dans la sclérose en plaques.
Rev. Med. Suisse 2006, 2:1166-1168, 1170.
22: Leimgruber A.
    Allergo-immunology.
Rev. Med. Suisse 2006, 2:89-92.
23: Leimgruber A.
    Anaphylaxie p182-183; Aspergillose allergique bronchopulmonaire p409; Urticaire et angioedème p410; Allergie aux hyménoptères p411; Maladie de Widal p420; Allergie à la Pénicilline p1021.
P. Furger. SURF Guide thérapeutique de Médecine interne et Diagnostic différentiel selon INVESTI-MED. Editions D & F GMBH, Suisse 2006, p1-1328.
24: Lurati Ruiz F., Audran R., Harari A. and Spertini F.
    Specific interferon-gamma assays: a modern tool for tuberculosis diagnosis.
Rev. Med. Suisse 2006, 2:1042, 1044-1047.
25: Mazzolai L., Hohlfeld P., Spertini F., Hayoz D., Schapira M. and Duchosal M.A.
    Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy.
Blood 2006, 108:1569-1570.
26: Pantaleo G. and Harari A.
    Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.
Nat. Rev. Immunol. 2006, 6:417-423.
27: Periard D., Mayor C., Aubert V. and Spertini F.
    Recurrent ibuprofen-induced aseptic meningitis: evidence against an antigen-specific immune response.
Neurology 2006, 67:539-540.
28: Perrier C., Sprenger N. and Corthésy B.
    Glycans on secretory component participate in innate protection against mucosal pathogens.
J. Biol. Chem. 2006, 281:14280-14287.
29: Robert D., Barelli S., Crettaz D., Bart P.-A., Schifferli J.A., Betticher D. and Tissot J.-D.
    Clinical proteomics: Study of a cryogel.
Proteomics 2006, 6:3958-3960.
30: Stern L.J., Potolicchio I. and Santambrogio L.
    MHC class II compartment subtypes: structure and function.
Curr. Opin. Immunol. 2006, 18:64-69.
31: Vulliemoz S., Lurati-Ruiz F., Borruat F.X., Delavelle J., Koralnik I.J., Kuntzer T., Bogousslavsky J., Picard F., Landis T. and Du Pasquier R.A.
    Favourable outcome of progressive multifocal leukoencephalopathy in two patients with dermatomyositis.
J. Neurol. Neurosurg. Psychiatry 2006, 77:1079-1082.
32: Wüthrich B., Frei P.C., Bircher A., Dayer E., Hauser C., Pichler W., Schmid-Grendelmeier P., Spertini F., Olgiati D. and Müller U.
    Sinnlose Allergietests: Stellungnahme der Fachkommission der Schweizerischen Gesellschaft für Allergologie und Immunologie (SGAI) zur IgG/IG4-Bestimmung gegen Nahrungsmittel.
Pipette Swiss Laboratory Medicine 2006, 2:9-12.
33: Weber B., Orazi B., Raineri A., Thorstensson R., Bürgisser P., Mühlbacher A., Areal C., Eiras A., Villaescusa R., Camacho R., Diogo I., Roth H.-J., Zahn I., Bartel J., Bossi V., Piro F., Atamasirikul K., Permpikul P., Webber L. and Singh S.
    Multicenter evaluation of a new 4th generation HIV screening assay elecsys HIV combi.
Clin. Lab. 2006, 52:463-473.
34: Zuber J.-P. and Spertini F.
    Immunological basis of systemic sclerosis.
Rheumatology (Oxford) 2006, 45 Suppl 3:iii23-iii25.
35: Zuber J.-P., Chizzolini C., Leimgruber A., Bart P.-A. and Spertini F.
    Pathogenic mechanisms in systemic sclerosis and their therapeutical consequences. Part 1: pathogenesis.
Rev. Med. Suisse 2006, 2:1052-1057.
36: Zuber J.-P., Chizzolini C., Leimgruber A., Bart P.-A. and Spertini F.
    Pathogenic mechanisms in systemic sclerosis and their therapeutical consequences. Part 2: treatment.
Rev. Med. Suisse 2006, 2:1058, 1060-1066.
37: Zuercher A.W., Fritsche R., Corthésy B. and Mercenier A.
    Food products and allergy development, prevention and treatment.
Curr. Opin. Biotechnol. 2006, 17:198-203.

Publications : 2005 Debut de page
1: Audran R., Cachat M., Lurati F., Soe S., Leroy O., Corradin G., Druilhe P. and Spertini F.
    Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen.
Infect. Immun. 2005, 73:8017-8026.
2: Castro E., Moreno M., Deibis L., de Pérez G., Salmen S. and Berrueta L.
    Trends of HIV-1 molecular epidemiology in Venezuela: introduction of subtype C and identification of a novel B/C mosaic genome.
J. Clin. Virol. 2005, 32:257-258.
3: Corthésy B., Boris S., Isler P., Grangette C. and Mercenier A.
    Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
J. Infect. Dis. 2005, 192:1441-1449.
4: Deruaz C.A., von Feilitzen A., Leimgruber A., Bart P.-A. and Spertini F.
    Skin tests in allergology: really so simple ?
Rev. Med. Suisse 2005, 1:997-1002.
5: Druilhe P., Spertini F., Soesoe D., Corradin G., Mejia P., Singh S., Audran R., Bouzidi A., Oeuvray C. and Roussilhon C.
    A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum.
PLoS Med. 2005, 2:e344.
6: Du Pasquier R.A., Autissier P., Zheng Y., Jean-Jacques J. and Koralnik I.J.
    Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies.
AIDS 2005, 19:2069-2076.
7: Dutoit V., Ciuffreda D., Comte D., Gonvers J.J. and Pantaleo G.
    Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection.
Eur. J. Immunol. 2005, 35:3493-3504.
8: Favre L., Spertini F. and Corthésy B.
    Secretory IgA possesses intrinsic modulatory properties stimulating mucosal and systemic immune responses.
J. Immunol. 2005, 175:2793-2800.
9: Favre O., Leimgruber A., Nicole A. and Spertini F.
    Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency.
Allergy 2005, 60:385-390.
10: Fontana M., Delarive P. and Panizzon R.G.
    Dermite caustique du visage après activation d'un air-bag: à propos d'un cas.
Ann. Dermatol. Venereol. 2005, 132:164-165.
11: Fontana M., Spertini F., Bart P.-A. and Leimgruber A.
    Syndrome oral croisé et allergies alimentaires.
Rev. Med. Suisse 2005, 1:1010-1017.
12: Granziera C., Michel P., Rossetti A.O., Lurati F., Reymond S. and Bogousslavsky J.
    Wegener Granulomatosis presenting with haemorragic stroke in a young adult.
J. Neurol. 2005, 252:615-616.
13: Harari A. and Pantaleo G.
    Understanding what makes a good versus a bad vaccine.
Eur. J. Immunol. 2005, 35:2528-2531.
14: Harari A., Vallelian F., Meylan P. and Pantaleo G.
    Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence.
J. Immunol. 2005, 174:1037-1045.
15: Legler D.F., Doucey M.-A., Schneider P., Chapatte L., Bender F.C. and Bron C.
    Differential insertion of GPI-anchored GFPs into lipid rafts of live cells.
FASEB J. 2005, 19:73-75.
16: Leimgruber A.
    La Triade de Widal (asthme-polypose nasale-intolérance à l'aspirine) : une anomalie du métabolisme inflammatoire.
Rev. Med. Suisse 2005, 1:15-18.
17: Lichterfeld M., Pantaleo G. and Altfeld M.
    Loss of HIV-1-specific T cell proliferation in chronic HIV-1 infection: cause or consequence of viral replication ?
AIDS 2005, 19:1225-1227.
18: Lurati Ruiz F. and Bart P.-A.
    New therapeutic strategies in ANCA-associated systemic vasculitis.
Rev. Med. Suisse 2005, 1:19-23.
19: Lurati Ruiz F. and Spertini F.
    Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis.
J. Rheumatol. 2005, 32:2167-2172.
20: Maecker H.T., Rinfret A., D'Souza P., Darden J., Roig E., Landry C., Hayes P., Birungi J., Anzala O., Garcia M., Harari A., Frank I., Baydo R., Baker M., Holbrook J., Ottinger J., Lamoreaux L., Epling C.L., Sinclair E., Suni M.A., Punt K., Calarota S., El-Bahi S., Alter G., Maila H., Kuta E., Cox J., Gray C., Altfeld M., Nougarede N., Boyer J., Tussey L., Tobery T., Bredt B., Roederer M., Koup R., Maino V.C., Weinhold K., Pantaleo G., Gilmour J., Horton H. and Sekaly R.P.
    Standardization of cytokine flow cytometry assays.
BMC Immunol. 2005, 6:13.
21: Nardelli-Haefliger D., Lurati F., Wirthner D., Spertini F., Schiller J.T., Lowy D.R., Ponci F. and De Grandi P.
    Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine.
Vaccine 2005, 23:3634-3641.
22: Rice J.C., Peng T., Spence J.S., Wang H.Q., Goldblum R.M., Corthésy B. and Nowicki B.J.
    Pyelonephritic Escherichia coli expressing P fimbriae decrease immune response of the mouse kidney.
J. Am. Soc. Nephrol. 2005, 16:3583-3591.
23: Roger T., Miconnet I., Schiesser A.L., Kai H., Miyake K. and Calandra T.
    Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression.
Biochem. J. 2005, 387:355-365.
24: Schluep M., Chofflon M., Kuntzer T. and Du Pasquier R.
    Traitements immunomodulateurs/suppresseurs en neurologie.
Rev. Med. Suisse 2005, 1:1229-1232.
25: Spertini F., Dayer J.M. and Gremion G.
    About the article "Sports and immunology-allergology.
Rev. Med. Suisse 2005, 1:987-988.
26: Spertini F.
    Allergo-immunology.1. Eosinophiles: old knowledge... and new pathologies.
Rev. Med. Suisse 2005, 1:10-14.
27: Wüthricha B., Frei P.C., Bircher A., Dayer E., Hauser C., Pichler W., Schmid-Grendelmeierg P., Spertini F., Olgiati D. and Müller U.
    Tests d'allergie inutiles. Prise de position de la Commission de spécialité de la Société Suisse d'Allergologie et Immunologie (SSAI) sur les déterminations des IgG/IgG4 contre les aliments.
Bulletin des médecins suisses 2005, 86:1569-1571.
28: Zimmerli S.C., Harari A., Cellerai C., Vallelian F., Bart P.-A. and Pantaleo G.
    HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells.
Proc. Natl. Acad. Sci. USA 2005, 102:7239-7244.
29: Zuber J.-P., Spertini F., Leimgruber A. and Bart P.-A.
    Sarcoidosis: new therapeutic and pathogenic aspects for an "old" disease.
Rev. Med. Suisse 2005, 1:1026, 1029-1034, 1036-1038.

Publications : 2004 Debut de page
1: Aubert V.
    Le point sur l'allergie: mécanismes et diagnostic in vitro.
Labmed 2004, 31:458-462.
2: Böni J., Bisset L.R., Burckhardt J.J., Joller-Jemelka H.I., Bürgisser P., Perrin L., Gorgievski M., Erb P., Fierz W., Piffaretti J.-C., Schüpbach J. and the Swiss HIV Cohort Study.
    Prevalence of human T-cell leukemia virus types I and II in Switzerland.
J. Med. Virol. 2004, 72:328-337.
3: Balla-Jhagjhoorsingh S.S., Koopman G., Mooij P., Koornstra W., McCormack S., Weber J., Pantaleo G., Heeney J.L.
    Long-term persistence of HIV-1 vaccine-induced CD4+CD45RA-CD62L-CCR7- memory T-helper cells.
AIDS 2004, 18:837-848.
4: Barbey C., Donatelli-Dufour N., Batard P., Corradin G. and Spertini F.
    Intranasal treatment with ovalbumin but not the major T cell epitope ovalbumin 323-339 generates interleukin-10 secreting T cells and results in the induction of allergen systemic tolerance.
Clin. Exp. Allergy 2004, 34:654-662.
5: Berdoz J. and Corthésy B.
    Human polymeric IgA is superior to IgG and single-chain Fv of the same monoclonal specificity to inhibit urease activity associated with Helicobacter pylori.
Mol. Immunol. 2004, 41:1013-1022.
6: Corbett M. and Kraehenbuhl JP.
    Lung immunity: necessity is the mother of induction.
Nat. Med. 2004, 10:904-905.
7: Corradin G., Spertini F. and Verdini A.
    Medicinal application of long synthetic peptide technology.
Expert Opin. Biol. Ther. 2004, 4:1629-1639.
8: Deruaz C. and Spertini F.
    Reply to: Modern histamine H1-receptor antagonists in the unified airway.
J. Allergy Clin. Immunol. 2004, 114:698-699.
9: Deruaz C., Leimgruber A., Berney M., Pradervand E. and Spertini F.
    Levocetirizine better protects than desloratadine in a nasal provocation with allergen.
J. Allergy Clin. Immunol. 2004, 113:669-676.
10: Deruaz C.A., Lapointe A.-K., Bart P.-A., Leimgruber A. and Spertini F.
    Latex: de l’allergie professionnelle au syndrome latex-fruit.
Méd. & Hyg. 2004, 62:421-426.
11: Didierlaurent A., Ferrero I., Otten L.A., Dubois B., Reinhardt M., Carlsen H., Blomhoff R., Akira S., Kraehenbuhl J.P. and Sirard, J.C.
    Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response.
J. Immunol. 172:6922-6930.
12: Didierlaurent A., Ramirez J.C., Gherardi M., Zimmerli S.C., Graf M., Acha-Orbea H., Pantaleo G., Wagner R., Esteban M., Kraehenbuhl J.-P. and Sirard J.C.
    Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses.
Vaccine 2004, 22:3395-3403.
13: Du Pasquier R.A., Schmitz J.E., Jean-Jacques J., Zheng Y., Gordon J., Khalili K., Letvin N.L. and Koralnik I.J.
    Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.
J. Virol. 2004, 78:10206-10210.
14: Eng P., Hauser C., Helbling A., Schmid-Grendelmeier P., Spertini F. and Bircher A.
    Spezifische Immuntherapie in der Schweiz - sublingual oder subkutan ? Immunothérapie spécifique en Suisse - sublinguale ou sous-cutanée ?
Schweiz Med. Forum 2004, 4:1269-1276.
15: Eperon S., Sauty A., Lanz R., Leimgruber A., Lurati F. and Guex-Crosier Y.
    Eotaxin-1 (CCL11) up-regulation in tears during seasonal allergic conjunctivitis.
Graefes Arch. Clin. Exp. Ophthalmol. 2004, 242:966-970.
16: Fontana M., Ruchat P., Horisberger J., Aubert V., Mayor C. and Spertini F.
    Prevention of cryoglobulins during extracorporeal circulation in a patient with HIV-HCV co-infections.
Swiss Med. Wkly 2004, 134 (suppl. 140):S8.
17: Harari A. and Pantaleo G.
    Functional characterization of HIV-1-specific CD4 T cells.
EPHIS Book, 2004.
18: Harari A., Petitpierre F., Vallelian F. and Pantaleo G.
    Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy.
Blood 2004, 103:966-972.
19: Harari A., Vallelian F. and Pantaleo G.
    Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load.
Eur. J. Immunol. 2004, 34:3525-3533.
20: Harari A., Zimmerli S. and Pantaleo G.
    Cytomegalovirus (CMV)-specific cellular immune responses.
Hum. Immunol. 2004, 65:500-506.
21: Jilek S., Walter E., Merkle H.P. and Corthésy B.
    Modulation of allergic responses in mice by using biodegradable poly(lactide-co-glycolide) microspheres.
J. Allergy Clin. Immunol. 2004, 114:943-950.
22: Kadaoui K.A. and Corthésy B.
    Isolation of dendritic cells from mouse Peyer's patches using magnetic cell sorting.
Customer Report MACS & more 2004, 8:10-13.
23: Katz-Brull R., Lenkinski R.E., Du Pasquier R.A. and Koralnik I.J.
    Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy.
Neurology 2004, 63:897-900.
24: Khonkarly M.B., Merlani G., Halfon P., Bellini C., Pellet A., Kazadi K., Cavassini M. and Tarr P.
    Infection VIH: dix points clefs pour la prise en charge par les praticiens.
Méd. & Hyg. 2004, 62:862-868.
25: Kraehenbuhl J.P. and Corbett M.
    Immunology. Keeping the gut microflora at bay.
Science 2004, 303:1624-1625.
26: Lapointe A.-L., Leimgruber A., Spertini F., Künzle N., Laffitte E. and Bart P.-A.
    Vasculites cutanées : les implications en immunologie clinique.
Méd. & Hyg. 2004, 62:430-436.
27: Leimgruber A.
    Médication.
Le Guide Suisse des allergies. Edition Mancassola, Le Mont-sur-Lausanne 2004, 4.3:109-112.
28: Lurati Ruiz F., Bart P.-A., Hofer M., Périard D., Leimgruber A. and Spertini F.
    Que doit retenir le praticien des immunodéficiences primaires ?
Méd. & Hyg. 2004, 62:451-458.
29: Niedergang F., Didierlaurent A., Kraehenbuhl J.P. and Sirard J.C.
    Dendritic cells: the host Achille's heel for mucosal pathogens ?
Trends Microbiol. 2004, 12:79-88.
30: Nobile M., Correa R., Borghans J.A., D'Agostino C., Schneider P., De Boer R.J. and Pantaleo G.
    De novo T-cell generation in patients at different ages and stages of HIV-1 disease.
Blood 2004, 104:470-477.
31: Périard D., Bart P.-A., Deruaz C.A., Spertini F. and Leimgruber A.
    Le syndrome des antiphospholipides.
Méd. & Hyg. 2004, 62:438-442.
32: Pantaleo G. and Kroup R.A.
    Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.
Nat. Med. 2004, 10:806-810.
33: Peyre M., Audran R., Estevez F., Corradin G., Gander B., Sesardic D. and Johansen P.
    Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions.
J. Control. Release 2004, 99:345-355.
34: Rey J., Garin N., Spertini F. and Corthésy B.
    Targeting of secretory IgA to Peyer's patch dendritic cells and T cells following transport by intestinal M cells.
J. Immunol. 2004, 172:3026-3033.
35: Rumbo M., Anderle P., Didierlaurent A., Sierro F., Debard N., Sirard J.C. and Kraehenbuhl J.P.
    How the gut links innate and adaptive immunity.
Ann. N.Y. Acad. Sci. 2004, 1029:16-21.
36: Rumbo M., Sierro F., Debard N., Kraehenbuhl J.P. and Finke D.
    Lymphotoxin ß receptor signaling induces the chemokine CCL20 in intestinal epithelium.
Gastroenterology 2004, 127:213-223.
37: Scherer A., Frater J., Oxenius A., Agudelo J., Price D.A., Günthard H.F., Barnardo M., Perrin L., Hirschel B., Phillips R.E., McLean A.R. and the Swiss HIV Cohort Study.
    Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS.
Proc. Natl. Acad. Sci. USA 2004, 101:12266-12270.
38: Spertini F., Perret-Menoud V., Barbier N., Chatila T., Barbey C. and Corthésy B.
    Epitope-specific crosslinking of CD45 down-regulates membrane-associated tyrosine phosphatase activity and triggers early signaling events in human activated T cells.
Immunology 2004, 113:441-452.
39: Spertini F.
    Désensibilisation.
Le Guide Suisse des allergies. Edition Mancassola, Le Mont-sur-Lausanne 2004, 4.4:113-117.
40: Stingele F., Corthésy B., Kusy N., Porcelli S.A., Kasper D.L. and Tzianabos A.O.
    Zwitterionic polysaccharides stimulate T cells with no preferential Vbeta usage and promote anergy resulting in protection against experimental abscess formation.
J. Immunol. 2004, 172:1483-1490.
41: Wood R., Phanuphak P., Cahn P., Pokrovskiy V., Rozenbaum W., Pantaleo G., Sension M., Murphy R., Mancini M., Kelleher T., and Giordano M.
    Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavir.
J. Acquir. Immune Defic. Syndr. 2004, 36:684-692.
42: Yerly S., Jost S., Monnat M., Telenti A., Cavassini M., Chave J.-P., Kaiser L., Bürgisser P., Perrin L. and the Swiss HIV Cohort Study.
    HIV-1 co/super-infection in intravenous drug users.
AIDS 2004, 18:1413-1421.
43: Yerly S., Jost S., Telenti A., Flepp M., Kaiser L., Chave J.-P., Vernazza P., Battegay M., Furrer H., Chanzy B., Bürgisser P., Rickenbach M., Gebhardt M., Bernard M.-C., Perneger T., Hirschel B., Perrin L. and the Swiss HIV Cohort Study.
    Infrequent transmission of HIV-1 drug-resistant variants.
Antivir. Ther. 2004, 9:375-384.

Publications : 2003 Debut de page
1: Aubert V.
    Ethique et laboratoire.
Croix-Rouge suisse 2003, Journal dossier 2, septembre:20-22.
2: Audran R., Peter K., Dannull J., Men Y., Scandella E., Groettrup M., Gander B. and Corradin G.
    Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro.
Vaccine 2003, 21:1250-1255.
3: Bart P.-A.
    Allergologie et immunologie clinique. Les immunosuppresseurs dans les maladies auto-immunes : nouveautés.
Méd. & Hyg. 2003, 61:14-20.
4: Bart P.-A., Lamy O., Vollenweider P. and Waeber G.
    Formation en Médecine Interne : de l'utilité des Case Reports.
Praxis 2003, 92:1711-1711.
5: Clot B., Felber F., Leimgruber A. and Spertini F.
    Atlas.
Plantes, Pollens et Allergies 2003, p.132-193.
6: Corthésy B.
    Recombinant secretory immunoglobulin A in passive immunotherapy: linking immunology and biotechnology.
Curr. Pharm. Biotechnol. 2003, 4:51-67.
7: Corthésy-Theulaz I., Corthésy B., Bachmann D., Velin D. and Kraehenbuhl J.-P.
    Passive immunity in Helicobacter-challenged neonatal mice conferred by immunized dams lasts until weaning.
Infect Immun. 2003, 71:2226-2229.
8: Deglon N., Aubert V., Spertini F., Winkel L. and Aebischer P.
    Presence of Gal-alpha1,3Gal epitope on xenogeneic lines: implications for cellular gene therapy based on the encapsulation technology.
Xenotransplantation. 2003, 10:204-213.
9: Deruaz C., Bart P.-A., Spertini F. and Leimgruber A.
    Approche anti-inflammatoire de la rhinite allergique.
Méd. & Hyg. 2003, 61:836-840.
10: Favre L., Spertini F. and Corthésy B.
    Simplified procedure to recover recombinant antigenized secretory IgA to be used as a vaccine vector.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003, 786:143-151.
11: Felber F., Clot B., Leimgruber A. and Spertini F.
    Plantes, Pollens et Allergies.
Presse de l'Université de Neuchâtel. 2003, p. 208.
12: Fellrath J.-M., Kettner A., Dufour N., Frigerio C., Schneeberger D., Leimgruber A., Corradin G. and Spertini F.
    Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptide results of a phase I trial.
J. Allergy Clin. Immunol. 2003, 111:854-861.
13: Gainon J., Bart P.-A. and Waeber G.
    Comment évaluer le risque oncologique d'un patient souffrant de dermatomyosite ?
Praxis 2003, 92:1734-1739.
14: Herbort C.P., Tao Tran V., Auer C. and Spertini F.
    Les uvéites: approche diagnostique multi-disciplinaire actualisée à l'usage de l'ophtalmologue et de l'interniste. Partie 2 : investigations systémiques en cas d’uvéite et apport de l’interniste.
Méd. & Hyg. 2003, 61:1519-1522.
15: Herbort C.P., Tao Tran V., Auer C. and Spertini F.
    Les uvéites: approche diagnostique multi-disciplinaire actualisée à l'usage de l'ophtalmologue et de l'interniste. Partie 1 : la démarche diagnostique en ophtlamologie.
Méd. & Hyg. 2003, 61:1371-1380.
16: Kaufmann G.R., Perrin L., Pantaleo G., Opravil M., Furrer H., Telenti A., Hirschel B., Ledergerber B., Vernazza P., Bernasconi E., Rickenbach M., Egger M. and Battegay M.
    CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Arch. Intern. Med. 2003, 163:2187-2195.
17: Klausner RD., Fauci AS., Corey L., Nabel GJ., Gayle H., Berkley S., Haynes BF., Baltimore D., Collins C., Douglas RG., Esparza J., Francis DP., Ganguly NK., Gerberding JL., Johnston MI., Kazatchkine MD., McMichael AJ., Makgoba MW., Pantaleo G., Piot P., Shao Y., Tramont E., Varmus H., Wasserheit JN.
    Medicine. The need for a global HIV vaccine enterprise.
Science 2003, 300:2036-2039.
18: Leimgruber A.
    Allergologie et immunologie clinique. Allergie et anaphylaxie : nouveautés thérapeutiques.
Méd. & Hyg. 2003, 61:12-13.
19: Leimgruber A.
    Les manifestations cliniques de l'allergie pollinique et leur traitement.
Plantes, Pollens et Allergies 2003, p 72-83.
20: Leimgruber A.
    Médication.
Le Guide Suisse des allergies. Edition Mancassola, Le Mont-sur-Lausanne 2003, p. 110-115.
21: Lu L., Lamm M.E., Li H., Corthésy B. and Zhang J.R.
    The human polymeric immunoglobulin receptor binds to Streptococcus pneumoniae via domains 3 and 4.
J. Biol. Chem. 2003, 278:48178-48187.
22: Lurati Ruiz F., Leimgruber A., Bart P.-A. and Spertini F.
    Intérêt des anticorps anti-cytoplasme des neutrophiles (ANCA) en clinique.
Méd. & Hyg. 2003, 61:830-834.
23: Matter M., Venetz J.-P., Aubert V., Gachet C., Burnier M. and Barbey F.
    Dual Transplant of Marginal kidneys. Case report and review of literature.
Swiss Surg. 2003, 9:213-215.
24: Meraldi V., Audran R., Romero J.F., Brossars V., Bauer J., Lopez J.A. and Corradin G.
    OM-174, a new adjuvant with a potential for human use, induces a prospective reponse when administred with the synthetic C-terminal fragment 242-310 from the circumsporozoite protein of Plasmodium berghei
Vaccine 2003, 21:2485-2491.
25: Mulherin S.A., O'Brien T.R., Ioannidis J.P., Goedert J.J., Buchbinder S.P., Coutinho R.A., Jamieson B.D., Meyer L., Michael N.L., Pantaleo G., Rizzardi G.P., Schuitemaker H., Sheppard H.W., Theodorou I.D., Vlahov D. and Rosenberg P.S; International Meta-Analysis of HIV Host Genetics.
    Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
AIDS 2003, 17:377-387. Comment in AIDS 2003, 17 Suppl. 4:S127-128.
26: Perrin E., Leimgruber A., Spertini F. and Bart P.-A.
    Connectivite mixte : mise au point.
Méd. & Hyg. 2003, 61:823-828.
27: Phalipon A. and Corthésy B.
    Novel functions of the polymeric Ig receptor: well beyond transport of immunoglobulins.
Trends Immunol. 2003, 24:55-58.
28: Spertini F. and Dayer J.-M.
    La formation continue : plus qu'un simple enseignement, un enjeu politique.
Méd. & Hyg. 2003 , 61:795-796.
29: Spertini F. and Longaretti C.
    Allergologie et immunologie clinique. Régulation de la réponse allergique et prévention primaire : stratégies parallèles ?
Méd. & Hyg. 2003, 61:8-11.
30: Spertini F.
    Augmentation de la fréquence des allergies : un problème de société.Plantes, Pollens et Allergies, p 124-131
Plantes, Pollens et Allergies 2003, p 124-13.
31: Spertini, F.
    Désensibilisation.
Le Guide Suisse des allergies. Edition Mancassola, Le Mont-sur-Lausanne, 2003, 4.4:116-121.
32: Spertini, F.
    Indications to specific immunotherapy in asthma.
Asthme de l'enfant et de l'adulte, Foundation for Education and Research in Allergy and Immunology, 2003, p 152-161.
33: Zuber J.-P., Deruaz C., Lobrinus J.A., Waeber G. and Bart P.-A.
    Périartérite noueuse et hépatite C : association fortuite ?
Praxis 2003, 92:1717-1725.

Publications : 2002 Debut de page
1: Ambresin A., Tran T., Spertini F. and Herbort C.
    Behcet's disease in Western Switzerland: epidemiology and analysis of ocular involvement.
Ocul. Immunol. Inflamm. 2002, 10:53-63.
2: Bart P.-A. and Pantaleo G.
    Immunodeficiencies associated with immunosuppressive agents.
In: Infectious Diseases. Cohen & Powderly. London (UK): Mosby.
3: Bart P.-A. and Pantaleo G.
    The immunopathogenesis of HIV-1 infection.
In: Infectious Diseases. Cohen & Powderly, London (UK): Mosby.
4: Bernasconi E., Germond J.E., Delley M., Fritsche R. and Corthésy B.
    Lactobacillus bulgaricus proteinase expressed in Lactococcus lactis is a powerful carrier for cell wall-associated and secreted bovine beta-lactoglobulin fusion proteins.
Appl. Environ. Microbiol. 2002, 68:2917-2923.
5: Corthésy B.
    Recombinant immunoglobulin A: powerful tools for fundamental and applied research.
Trends Biotechnol. 2002, 20:65-71.
6: Corthésy B.
    Recombinant secretory immunoglobulin A: from fundamental to applied research in mucosal immunology.
Recent Res. Devel. Immunology 2002, 4:463-477.
7: Corthésy B.
    Treatment of allergy using DNA vaccination.
BioWorld 6 2002, pp. 463-477.
8: Cottet S., Corthésy-Theulaz I., Spertini F. and Corthésy B.
    In vitro microaerophilic conditions permit to mimic events occurring during in vivo Helicobacter pylori infection, and identify Rho/Ras-associated proteins in cellular signalling.
J. Biol. Chem. 2002, 277:33978-33986.
9: Ellefsen K., Harari A., Champagne P., Bart P.-A., Sékaly R.P. and Pantaleo G.
    Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections.
Eur. J. Immunol. 2002, 32:3756-3764.
10: Fellay J., Marzolini C., Meaden E.R., Back D.J., Buclin T., Chave J.P., Decosterd L.A., Furrer H., Opravil M., Pantaleo G., Retelska D., Ruiz L., Schinkel A.H., Vernazza P., Eap C.B. and Telenti A.
    Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.
Lancet 2002, 359:30-36.
11: Fotopoulos G., Harari A., Michetti P., Trono D., Pantaleo G. and Kraehenbuhl J.-P.
    Transepithelial transport of HIV-1 by M cells is receptor-mediated.
Proc. Natl. Acad. Sci. USA 2002, 99:9410-9414.
12: Greub G., Gallant S., Zurn P., Vannotti M., Bürgisser P., Francioli P., Zanetti G. and Telenti A.
    Spare non-occupational HIV post-exposure prophylaxis by active contacting and testing of the source person.
AIDS 2002, 16:1171-1176.
13: Harari A., Ellefsen K., Champagne P., Nobile M. and Pantaleo G.
    Antiviral memory T cell responses: correlation with protective immunity and implication for vaccine development.
Adv. Exp. Med. Biol. 2002, 512:155-164.
14: Harari A., Rizzardi G.P., Ellfesen K., Ciuffreda D., Champagne P., Bart P.-A., Kaufmann D., Telenti A., Sahli R., Tambussi G., Kaiser L., Lazzarin A., Perrin L. and Pantaleo G.
    Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses
during primary and chronic infection.
Blood 2002, 100:1381-1387.
15: Leimgruber A.
    La desloratadine, un nouvel antihistaminique : plus puissant ?
Méd. & Hyg. 2002, 60:12-14.
16: Mantis N.J., Cheung M.C., Chintalacharuvu K.R., Rey J., Corthésy B. and Neutra M.R.
    Selective adherence of IgA to murine Peyer's patch M cells: evidence for a novel IgA receptor.
J. Immunol. 2002, 169:1844-1851.
17: Phalipon A., Cardona A., Kraehenbuhl J.-P., Edelman L., Sansonetti P.J. and Corthésy B.
    Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo.
Immunity 2002, 17:107-115.
18: Prior J.O., Boubaker A., Spertini F. and Delaloye A.B.
    Lymphoscintigraphy in a patient with polyserositis of unknown origin.
Clin. Nucl. Med. 2002, 27:905-906.
19: Rizzardi G.P., Harari A., Capiluppi B., Tambussi G., Ellefsen K., Ciuffreda D., Champagne P., Bart P.-A., Chave J.P., Lazzarin A. and Pantaleo G.
    Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy.
J. Clin. Invest. 2002, 109:681-688.
20: Rizzardi G.P., Lazzarin A. and Pantaleo G.
    Potential role of immune modulation in the effective long-term control of HIV-1 infection.
J. Biol. Regul. Homeost. Agents 2002, 16:83-90.
21: Spertini F. and Sauty A.
    Combinaisons thérapeutiques dans l'asthme.
Méd. & Hyg. 2002, 60:8-14.
22: Suter M., Martinet O. and Spertini F.
    Reduced acute phase response after laparoscopic total extraperitoneal bilateral hernia repair compared to open repair with the Stoppa procedure.
Surg. Endosc. 2002, 16:1214-1219.
23: Telenti A., Aubert V. and Spertini F.
    Individualising HIV treatment--pharmacogenetics and immunogenetics.
Lancet 2002, 359:722-723.
24: Tissot J.D., Vu D.H., Aubert V., Schneider P., Vuadens F., Crettaz D. and Duchosal M.A.
    The immunoglobulinopathies: From physiopathology to diagnosis.
Proteomics 2002, 2:813-824.
25: Von Garnier C., Astori M., Kettner A., Dufour N., Corradin G. and Spertini F.
    In vivo kinetics of the immunoglobulin E response to allergen: bystander effect of coimmunization and relationship with anaphylaxis.
Clin. Exp. Allergy 2002, 32:401-410.
26: Weber B., Gurtler L., Thorstensson R., Michl U., Muhlbacher A., Burgisser P., Villaescusa R., Eiras A., Gabriel C., Stekel H., Tanprasert S., Oota S., Silvestre M.J., Marques C., Ladeira M., Rabenau H., Berger A., Schmitt U. and Melchior W.
    Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity.
J. Clin. Microbiol. 2002, 40:1938-1946.
27: Yu J., Cassels F., Scharton-Kersten T., Hammond S.A., Hartman A., Angov E., Corthésy B., Alving C. and Glenn G.
    Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
Infect. Immun. 2002, 70:1056-1068.
28: Zippelius A., Pittet M.J., Batard P., Rufer N., de Smedt M., Guillaume P., Ellefsen K., Valmori D., Liénard D., Plum J., MacDonald H.R., Speiser D.E., Cerottini J.-C. and Romero P.
    Thymic selection generates a large T cell pool recognizing a self-peptide in humans.Thymic selection generates a large T cell pool recognizing a self-peptide in humans.
J. Exp. Med. 2002, 195:485-494.


Dernière modification le 13.09.2010 - Impressum - Informations juridiques

Home
Organisation Clinique Diagnostic Formation